L. Lorini

发表

Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific Therapies

P. Nuciforo, S. Simonetti, U. Müller-Richter, 2021, Cancers.

Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders

S. Calza, C. Magri, F. Facchetti, 2022, Frontiers in Oncology.

Confounding factors in the assessment of oral mucositis in head and neck cancer

I. Braña, S. Elad, P. Bossi, 2022, Supportive Care in Cancer.

New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

M. Ravanelli, P. Bossi, C. Romani, 2022, Vaccines.

Treatment of Cutaneous Squamous Cell Carcinoma with Immune Checkpoint Inhibitors in Special Populations

P. Bossi, L. Lorini, 2021, Dermatology practical & conceptual.

Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma.

M. Ravanelli, D. Farina, R. Maroldi, 2022, Oral oncology.

Comparison of platinum-based regimens in combination with radiotherapy for head and neck cancers: A network meta-analysis.

F. Petrelli, P. Bossi, V. Capriotti, 2022, Oral oncology.

Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma.

M. Ravanelli, D. Farina, D. Lombardi, 2021, Oral oncology.

Confounding factors in the assessment of oral mucositis in head and neck cancer

I. Braña, S. Elad, P. Bossi, 2022, Supportive Care in Cancer.

Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group

J. Machiels, P. Bossi, C. Simon, 2022, Frontiers in Oncology.

Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study

D. Lombardi, P. Bossi, M. Tomasoni, 2022, Scientific Reports.

Antineoplastic activity of artemisinin in adrenocortical carcinoma

G. Tiberio, S. Grisanti, L. Grazioli, 2019, Endocrine.

Optimal Supportive Measures during Primary Treatment

P. Bossi, L. Lorini, 2021, Critical Issues in Head and Neck Oncology.

In vitro and in vivo evaluation of cytotoxic effect of targeted agents alone or in combination with chemotherapy for the treatment of adenoid cystic carcinoma

M. Memo, D. Lombardi, P. Bossi, 2021 .

Not all hematopoietic growth factors are created equal: should we gain information for their use with immunotherapy?

M. Merlano, P. Bossi, C. Gurizzan, 2021, Journal for ImmunoTherapy of Cancer.

Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers

M. Hermsen, P. Bossi, N. London, 2022, Journal of clinical medicine.

Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways

S. Calza, M. Ravanelli, D. Lombardi, 2023, Scientific Reports.

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in Older Patients: Are New Agents Bringing New Hope?

P. Bossi, J. Vermorken, M. Cossu Rocca, 2023, Drugs & Aging.

Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial

L. De Cecco, R. Miceli, M. Serafini, 2021, BMC cancer.

Oral potentially malignant disorders: new insights for future treatment.

P. Bossi, L. Lorini, C. Gurizzan, 2020, Current opinion in otolaryngology & head and neck surgery.

Gene Expression Profiling of Olfactory Neuroblastoma Helps Identify Prognostic Pathways and Define Potentially Therapeutic Targets

S. Calza, F. Sessa, R. Maroldi, 2021, Cancers.

The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports

L. Licitra, C. Resteghini, L. Locati, 2023, Frontiers in Oncology.

Comparison of different treatments for HPV+ oropharyngeal carcinoma: a network meta-analysis

F. Petrelli, P. Bossi, A. Luciani, 2022, European Archives of Oto-Rhino-Laryngology.

864MO Role of geriatric assessment in tailoring treatment of locally advanced head and neck cancer: The ELDERLY study

L. Licitra, P. Bonomo, P. Nicolai, 2021, Annals of Oncology.

Is it time to tailor treatments in androgen receptor positive salivary gland cancers?

P. Bossi, S. Grisanti, A. Berruti, 2023, Oral oncology.

Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic

P. Bossi, R. Pedersini, S. Grisanti, 2021, Frontiers in Oncology.

Immunotherapy followed by cetuximab in locally advanced/metastatic (LA/M) cutaneous squamous cell carcinomas (cSCC): The I-TACKLE trial.

P. Ascierto, L. Licitra, C. Resteghini, 2022, Journal of Clinical Oncology.

Advanced Cutaneous Squamous Cell Carcinoma Management in Immunotherapy Era: Achievements and New Challenges

L. Lorini, Andrea Alberti, Paolo Bossi, 2023, Dermatology practical & conceptual.

HER2-targeted therapies for salivary gland cancers.

L. Presutti, S. Alfieri, D. Filippini, 2023, Oral oncology.

Is precision medicine the solution to improve organ preservation in laryngeal/hypopharyngeal cancer? A position paper by the Preserve Research Group

E. Hovig, Ksenia Khelik, D. Mattavelli, 2024, Frontiers in Oncology.

The Use of Artificial Intelligence in Head and Neck Cancers: A Multidisciplinary Survey

M. Scorsetti, E. Casiraghi, C. Franzese, 2024, Journal of personalized medicine.

Immunotherapy in elderly head and neck cancer patients: a systematic review and meta-analysis

S. Caini, L. Lorini, V. Salvestrini, 2024, Frontiers in oncology.

The predictive role of PD-L1 in head and neck cancer: A systematic review and meta-analysis.

C. Gurizzan, L. Lorini, Vincenzo Capriotti, 2024, Oral oncology.

Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy.

M. Ravanelli, D. Mattavelli, A. Paderno, 2023, Cancer treatment reviews.